Počet záznamov: 1
lupus antikoagulans
SYS d016682 LBL 00000cx--j2200000---45-- 005 20240119201303.4 100 $a 19920712asloy0103----ba0 152 $b mesh 250 $a lupus antikoagulans $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 92; was LUPUS COAGULATION INHIBITOR (NM) 1978-91 $8 eng 300 1-
$a Autoantibodies (1966-1991) $8 eng 300 1-
$a Blood Coagulation Factors (1966-1991) $8 eng 330 1-
$a An antiphospholipid antibody found in association with a variety of diseases (e.g., SYSTEMIC LUPUS ERYTHEMATOSUS and ANTIPHOSPHOLIPID SYNDROME) as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications. $8 eng 450 $a Lupus Anticoagulant $5 e $8 eng 450 $a Lupus Anticoagulant Autoantibodies $5 e $8 eng 450 $a Lupus Anticoagulant Autoantibody $5 e $8 eng 450 $a inhibítor koagulácie, lupusový $5 e $8 slo 450 $a antikoagulant lupusový $5 e $8 slo 450 $a autoprotilátky lupusové antikoagulačné $5 e $8 slo 450 $a autoprotilátka antikoagulačná lupusová $5 e $8 slo 550 $3 sllk_un_auth*d008180 $Y Lupus Erythematosus, Systemic $5 B $a lupus erythematosus, systémový 550 $3 sllk_un_auth*d007155 $Y Immunologic Factors $5 P $a faktory imunologické 550 $3 sllk_un_auth*d016736 $Y Antiphospholipid Syndrome $5 F $a syndróm antifosfolipidový 686 $a D12.776.124.486.485.114.323.210.600 686 $a D12.776.124.790.651.114.323.210.600 686 $a D12.776.377.715.548.114.323.210.600 686 $a D23.113.475 750 $a Lupus Coagulation Inhibitor $8 eng 801 -0
$a US $b DNLM $c 19920712 801 -2
$a SK $b BA006 $c 20070706 801 -2
$a SK $b BA006 $c 20150424 801 -2
$a SK $b BA006 $c 20230829 980 $x M
Počet záznamov: 1